Detalhe da pesquisa
1.
Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A.
Malar J
; 18(1): 13, 2019 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30658710
2.
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.
J Infect Dis
; 213(11): 1743-51, 2016 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908756
3.
A field trial to assess a blood-stage malaria vaccine.
N Engl J Med
; 365(11): 1004-13, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21916638
4.
Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications.
J Infect Dis
; 207(3): 511-9, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23204168
5.
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.
Med
; 2(6): 701-719.e19, 2021 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223402
6.
Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate.
Vaccine
; 34(23): 2546-55, 2016 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27087149
7.
Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine.
Mol Biochem Parasitol
; 128(2): 195-204, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12742586
8.
Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial.
PLoS One
; 8(11): e79323, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24260195
9.
Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.
PLoS One
; 5(2): e9041, 2010 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20140214
10.
High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model.
PLoS One
; 4(12): e8138, 2009 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19997632
11.
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.
PLoS One
; 4(4): e5254, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19390585
12.
Enzyme-linked immunosorbent assay for detection of Plasmodium falciparum histidine-rich protein 2 in blood, plasma, and serum.
Clin Vaccine Immunol
; 15(6): 1012-8, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18367583
13.
Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial.
PLoS One
; 3(1): e1465, 2008 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-18213374
14.
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.
Vaccine
; 25(1): 176-84, 2007 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-16388879
15.
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
Vaccine
; 25(21): 4203-12, 2007 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-17442466
16.
The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.
Infect Immun
; 73(1): 287-97, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15618165
17.
Delayed-type hypersensitivity in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites.
Vaccine
; 20(13-14): 1853-61, 2002 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11906775
18.
Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites.
Vaccine
; 21(3-4): 269-80, 2002 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-12450702
19.
Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum.
Vaccine
; 22(29-30): 3831-40, 2004 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-15364429
20.
Recent developments in vaccination against malaria: Immunization of Aotus trivirgatus against Plasmodium falciparum with irradiated blood forms*
Bull. W.H.O. (Print)
; 57(Suppl): 153-157, 1979.
Artigo
em Inglês
| WHOLIS | ID: who-261829